Technology Description: Robossis Alpha is a surgical robotic system for orthopedic trauma procedures involving long-bone fractures. These procedures often rely on manual traction, surgeon experience, and repeated fluoroscopic imaging, which can contribute to variable alignment, longer cases, and radiation exposure. The system combines a compact surgical robot, adaptive motion cart, bone attachment approach, and surgeon-facing controls to support controlled reduction, accurate alignment, and guided instrument positioning in workflows such as intramedullary (IM) nailing.
Potential Applications / Applicability: Orthopedic trauma surgery; femur, tibia, and humerus fracture reduction; intramedullary (IM) nailing; trauma centers; teaching hospitals; surgical robotics development.
Key Benefits:
Opportunity: Rowan is seeking licensing, collaboration, and co-development partners in orthopedic devices, surgical robotics, navigation, and trauma-care workflows. Partner engagement may support engineering refinement, workflow validation, regulatory planning, and commercialization; patent application pending.
Development Status: Robossis Alpha is at the prototype/preclinical stage. Prototype hardware and workflow concepts have been evaluated in cadaver-lab femur fracture reduction and intramedullary nailing workflows, with further work focused on engineering refinement, usability optimization, validation, and regulatory clearance.
Patent information: Patent Pending